UDP-glucuronosyltransferase, the role of the amino terminus in dimerization

被引:95
作者
Meech, R [1 ]
Mackenzie, PI [1 ]
机构
[1] FLINDERS UNIV S AUSTRALIA,MED CTR,DEPT CLIN PHARMACOL,SCH MED,BEDFORD PK,SA 5042,AUSTRALIA
关键词
D O I
10.1074/jbc.272.43.26913
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
UDP-glucuronosyltransferases (UGTs) comprise an important enzyme system in mammals that is involved in detoxification of a variety of small hydrophobic compounds of both endogenous and exogenous origin, Some evidence suggests that these enzymes may function as oligomers; however, little is known about the domain of interaction or the mechanism of oligomerization, In this work, evidence for a functional dimerization between UGTs is provided by studies on mutated forms of UGTSB1. When two inactive forms of UGT2B1 were coexpressed in cell culture, catalytic activity was restored, indicating that UGT2B1 forms functional dimers. To delineate the dimerization domain, inactive fusion proteins containing the amino-or carboxyl-terminal domains of UGT2B1 were generated and expressed with active UGT2B1, Expression of a fusion protein containing only the amino-terminal half of UGT2B1 with active UGT2B1 caused a reduction in UGT2B1 catalytic activity, This reduction in activity was not observed when UGT2B1 was co-expressed with a fusion protein containing only the carboxyl terminal half of UGT2B1, strongly suggesting that the amino-terminal domain is involved in dimerization. Truncation of the immediate amino terminus of UGT2B1 abolished UGT2B1 activity and dimer formation. Activity was also abolished by an L4R substitution in this region of the mature protein, which is highly conserved in the UGT family. These results indicate that UGTs can interact through their amino-terminal domains to form catalytically active dimers. Possible mechanisms resulting in the formation and stabilization of the UGT2B1 dimer are discussed.
引用
收藏
页码:26913 / 26917
页数:5
相关论文
共 24 条
[11]   The UDP glycosyltransferase gene superfamily: Recommended nomenclature update based on evolutionary divergence [J].
Mackenzie, PI ;
Owens, IS ;
Burchell, B ;
Bock, KW ;
Bairoch, A ;
Belanger, A ;
FournelGigleux, S ;
Green, M ;
Hum, DW ;
Iyanagi, T ;
Lancet, D ;
Louisot, P ;
Magdalou, J ;
Chowdhury, JR ;
Ritter, JK ;
Schachter, H ;
Tephly, TR ;
Tipton, KF ;
Nebert, DW .
PHARMACOGENETICS, 1997, 7 (04) :255-269
[12]  
MACKENZIE PI, 1995, REV BIOCHEM TOXICOL, V11, P29
[13]  
MACKENZIE PI, 1990, FRONTIERS BIOTRANSFO, V2, P211
[14]  
MATERN H, 1982, J BIOL CHEM, V257, P7422
[15]   Mutational analysis of the carboxy-terminal region of UDP-glucuronosyltransferase 2B1 [J].
Meech, R ;
Yogalingam, G ;
Mackenzie, PI .
DNA AND CELL BIOLOGY, 1996, 15 (06) :489-494
[16]  
MORTLOCK D, 1993, J TISSUE CULTURE MET, V15, P176
[17]   THE NOVEL BILIRUBIN PHENOL UDP-GLUCURONOSYLTRANSFERASE UGT1 GENE LOCUS - IMPLICATIONS FOR MULTIPLE NONHEMOLYTIC FAMILIAL HYPERBILIRUBINEMIA PHENOTYPES [J].
OWENS, IS ;
RITTER, JK .
PHARMACOGENETICS, 1992, 2 (03) :93-108
[18]  
PETERS WHM, 1984, J BIOL CHEM, V259, P1701
[19]  
PRITCHARD M, 1994, MOL PHARMACOL, V45, P42
[20]  
RITTER JK, 1992, J BIOL CHEM, V267, P3257